Medicare
The Senate Finance Committee yesterday introduced 22 bipartisan bills to address the opioid crisis in Medicare, Medicaid and human services programs.
The Comprehensive Primary Care Initiative reduced hospitalizations and emergency department visits and improved primary care delivery for beneficiaries, but did not reduce Medicare spending enough to cover care management fees or significantly improve quality.
AHA statement before the Senate Finance Committee on "Rural Health Care in America: Challenges and Opportunities."
Health care is changing as the march from volume to value moves forward. And hospitals and health systems are redefining the 鈥淗鈥 to meet the demands of the moment, and of the future, in a way that is even more responsive to our patients and communities.
Medicare D prescription drug plan should not prevent pharmacies from telling customers when they could pay less for a drug by paying cash, the Centers for Medicare & Medicaid Services told plan sponsors yesterday.
May 2, 2018
RE: Quality Measures to Satisfy the Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) domain of: Transfer of Health Information and Care Preferences When an Individual Transitions 鈥 Medication Profile Transferred to Provider / Medication Profile Transferred to鈥
Government administered pricing at the Medicare level for all purchasers of health care services 鈥 as suggested in a recent opinion piece that appeared in the Washington Post titled, 鈥淭here鈥檚 a genuine sol
The Centers for Medicare & Medicaid Services (CMS) April 24 released its fiscal year (FY) 2019 proposed rule for the hospital inpatient and long-term care hospital (LTCH) prospective payment systems (PPS). A detailed summary of the proposed rule follows in the Regulatory Advisory below.
The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information.
Health and Human Services Secretary Alex Azar today provided additional information on steps the agency will take to implement the president鈥檚 blueprint to lower prescription drug costs.